Journal
BIOMARKERS IN MEDICINE
Volume 7, Issue 1, Pages 169-186Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/BMM.12.96
Keywords
electrostimulation; exercise; diabetes mellitus; hypoxia; inclusion body myositis; motor neuron disease; muscular atrophy; muscular dystrophy; myotonia; sarcopenia
Categories
Funding
- Irish Health Research Board
- Muscular Dystrophy Ireland
Ask authors/readers for more resources
Disease-specific biomarkers play a central diagnostic and therapeutic role in muscle pathology. Serum levels of a variety of muscle-derived enzymes are routinely used for the detection of muscle damage in diagnostic procedures, as well as for the monitoring of physical training status in sports medicine. Over the last few years, the systematic application of mass spectrometry-based proteomics for studying skeletal muscle degeneration has greatly expanded the range of muscle biomarkers, including new fiber-associated proteins involved in muscle transformation, muscular atrophy, muscular dystrophy, motor neuron disease, inclusion body myositis, myotonia, hypoxia, diabetes, obesity and sarcopenia of old age. These mass spectrometric studies have clearly established skeletal muscle proteomics as a reliable method for the identification of novel indicators of neuromuscular diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available